Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 20;75(1):98–102. doi: 10.1097/FJC.0000000000000764

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

FIGURE 1. — Effect of IL-15 on left ventricular function and infarct size. A, MI was induced in C57BL/6 mice at day 0. IL-15 (10 μg) or saline as control was administered through IP injection every 6 hours into the animals twice at the day of MI and 3 times on the following days as indicated. B–C, Left ventricular function was evaluated by echocardiography on the day before MI (−1) and at days 1 and 28 after MI. B, IL-15 significantly improved LVEF. C, Stroke volume was significantly higher after IL-15 treatment. D, On average, IL-15 treatment significantly reduced the infarct size by 1.7-fold. E, As indicated by Masson's trichrome staining in the representative figures, IL-15 treatment resulted significantly reduced infarct size compared with the saline-treated control. IL-15, n = 28. saline, n = 26. *P < 0.05. Error bars are SEM.

Inline graphic — Effect of IL-15 on left ventricular function and infarct size. A, MI was induced in C57BL/6 mice at day 0. IL-15 (10 μg) or saline as control was administered through IP injection every 6 hours into the animals twice at the day of MI and 3 times on the following days as indicated. B–C, Left ventricular function was evaluated by echocardiography on the day before MI (−1) and at days 1 and 28 after MI. B, IL-15 significantly improved LVEF. C, Stroke volume was significantly higher after IL-15 treatment. D, On average, IL-15 treatment significantly reduced the infarct size by 1.7-fold. E, As indicated by Masson's trichrome staining in the representative figures, IL-15 treatment resulted significantly reduced infarct size compared with the saline-treated control. IL-15, n = 28. saline, n = 26. *P < 0.05. Error bars are SEM.